CovID Vaccine Effectiveness

Andrew Mitchell made this Official Information request to Health Research Council of New Zealand

Health Research Council of New Zealand did not have the information requested.

From: Andrew Mitchell

Dear Health Research Council of New Zealand,

1. Does the Government et al have figures from placebo-controlled, randomised and blinded scientific studies that provide statistically significant evidence that subjects treated with the substance BNT162b2 so-called (“Comirnaty-COVID-19 vaccine” from BioNTech/Pfizer”) have overall suffered fewer medically undesirable events as subjects who received this placebo, and
2. If so, what are they, and
3. What is the date of the most recent analysis of the numbers at which time the criteria of placebo-controlled, randomised and blinded were still met?

Yours faithfully,

Andrew

Link to this

From: Lon Lana
Health Research Council of New Zealand

Morena Andrew

I hereby acknowledge receipt of your OIA request. We will respond within 20 working days.

Ngâ mihi

Lana Lon
Project Manager Ethics
Health Research Council of New Zealand
Te Kaunihera Rangahau Hauora o Aotearoa
PO Box 5541, Victoria Street West, Auckland, New Zealand 1142
DDI: 64 9 303 5221
Email: [email address] | http://www.hrc.govt.nz/

show quoted sections

Link to this

From: Lon Lana
Health Research Council of New Zealand


Attachment image001.jpg
124K Download

Attachment 30 August 2023 response to Covid vaccine effectiveness final.pdf
188K Download View as HTML


Kia ora Andrew

 

Please find attached our repsosne to your OIA request.

 

Ngā mihi

 

Lana Lon

Project Manager Ethics

Health Research Council of New Zealand

Te Kaunihera Rangahau Hauora o Aotearoa

PO Box 5541, Victoria Street West, Auckland, New Zealand 1142

DDI: 64 9 303 5221

Email: [1][email address] | [2]www.hrc.govt.nz

 

 

 

 

show quoted sections

Link to this

Things to do with this request

Anyone:
Health Research Council of New Zealand only: